2005 to 2019 Saw Increase in Incidence of Cervical Artery Dissection
By Elana Gotkine HealthDay Reporter
FRIDAY, April 4, 2025 -- Cervical artery dissection (CeAD) incidence increased from 2005 to 2019, with the increase in admissions particularly high in older, Black, and Hispanic populations, according to a study published online April 2 in Neurology.
Liqi Shu, M.D., from The Warren Alpert Medical School of Brown University in Providence, Rhode Island, and colleagues determined national trends in CeAD admissions and examined post-CeAD risk for ischemic stroke using data from the National Inpatient Sample (2005 to 2019), National Readmission Database (2015 to 2019), and State Inpatient Database for New York (2011 to 2017) and Florida (2011 to 2019).
A total of 125,102 patients with spontaneous CeAD were identified from 2005 to 2019. The researchers observed an increase in CeAD incidence from 10.7 to 45.6 cases per million population from 2005 to 2019, with an average annual percent change (AAPC) of 10.21 percent. In the older, Black, and Hispanic populations, this increase in CeAD admissions was particularly high. The upward trend was corroborated in statewide data, with an AAPC of 8.47 percent. Vertebral artery dissection was the sole major predictor of subsequent ischemic stroke risk within 90 days among patients with CeAD without acute ischemic stroke (adjusted subdistributed hazard ratio, 1.77). Similar results were seen in interaction and subgroup analyses.
"Our data highlight the importance of increased clinical vigilance to avert recurrent stroke, and future research should target the most efficacious treatment modalities for vertebral artery dissection," the authors write.
Several authors disclosed ties to the biopharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-05 06:00
Read more

- Unnecessary Imaging Scans Contributing To Climate Change
- Lawmakers Want School Meal Programs to Allow Whole Milk Again
- Lifetime Excess Weight, Adult Weight Gain Linked to Increased Renal Cancer Risk
- Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
- Free COVID-19 Test Program Stops Taking Orders
- Retiring Abroad May Lead to More Loneliness, Study Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions